Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 -57.26M
June 30, 2026 -13.44M
March 31, 2026 -5.107M
December 31, 2025 -108.07M
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 -0.016M
December 31, 2024 -0.104M
September 30, 2024 -39.93M
June 30, 2024 2.882M
March 31, 2024 -0.029M
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.029M
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.21M
December 31, 2021 -0.755M
Date Value
September 30, 2021 -97.26M
June 30, 2021 -0.004M
March 31, 2021 -0.014M
December 31, 2020 0.00
September 30, 2020 0.385M
June 30, 2020 -48.78M
March 31, 2020 -25.60M
December 31, 2019 0.019M
September 30, 2019 -1.254M
June 30, 2019 -1.26M
March 31, 2019 -12.32M
December 31, 2018 -1.177M
September 30, 2018 1.284M
June 30, 2018 -1.008M
March 31, 2018 -15.00M
December 31, 2017 -17.90M
September 30, 2017 0.00
June 30, 2017 -0.02M
March 31, 2017 -29.10M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Indaptus Therapeutics, Inc. 0.327M
Cue Biopharma, Inc. -50.63M
Yarrow Bioscience, Inc. -265.00M
Faeth Therapeutics, Inc. -0.104M
Pyxis Oncology, Inc. -38.62M